THE CARDIOPROTECTIVE EFFECTS OF THE ANTI-HYPERGLYCEMIC MEDICATION CLASS KNOWN AS GLP-1 RA.
NOT JUST YOUR AVERAGE WEIGHT LOSS DRUG
Diabetes Type 2 Ominous Octet
Defined
Pathophysiology
Chronic complications
Obesity/Overweight/Elevated BMI
Defined
Pathophysiology
Chronic complications
Psychological impact
GLP-1 RA
Reasons for development
Indications for use
Diabetes and cardiovascular protection
Mechanism of action
Off label for use for obesity
Contraindications